|
23 October 2017 |
Futura Medical plc
("Futura" or "the Company")
PDMR Dealing
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has purchased 19,581 shares of 0.2p each in the Company ("Ordinary Shares") into her Self-Invested Personal Pension ("SIPP").
Further details are contained within the notification below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
For further information please contact:
|
Futura Medical plc |
|
James Barder, Chief Executive + 44 (0) 1483 685 670 |
|
N+1 Singer (Nominated Adviser and Broker) |
|
For media enquiries please contact: |
|
Buchanan |
|
Mark Court / Sophie Wills /Stephanie Watson + 44 (0) 20 7466 5000 |
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Rachael Hawken |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR |
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Futura Medical plc |
||||
|
b) |
LEI |
21380053QLT46UNV2303 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.2p each GB0033278473 |
||||
|
b) |
Nature of the transaction |
Transfer of shares to SIPP through purchase by SIPP |
||||
|
c) |
Prices and volumes |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
19,581 ordinary shares of 0.2p each 24.13447 pence |
||||
|
e) |
Date of the transaction |
(i) 18 October 2017 (ii) 23 October 2017 |
||||
|
f) |
Place of the transaction |
(i) XLON (ii) XLON |
||||
This information is provided by RNS